Ym Biosciences’ Nimotuzumab Approved For Marketing In Mexico
YM BioSciences has reported that nimotuzumab has been approved for marketing in Mexico. YM BioSciences also announced that it has enrolled the first two patients in its randomised,
Insilico Medicine has entered into a strategic collaboration agreement with Takeda to deploy its AI-based Pharma.AI platform in the discovery and development of drug candidates.
RainDance Technologies and CLC bio have announced a partnership to develop specialised software for the analysis of targeted resequencing data generated by workflows incorporating RainDance’s Sequence Enrichment Solution